Cargando…
Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection
While there is absolutely no evidence to ensure recovered patients are either likely or unlikely to get reinfected. But studies in non-human primates indicate that reinfection of recovered patients is highly unlikely. It is also clear that primary immune responses or induced immunity to severe acute...
Autores principales: | Shrestha, Rupendra, Shrestha, Reena, Khadka, Ram Bahadur, Gyawali, Rabin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of the Nepal Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107855/ https://www.ncbi.nlm.nih.gov/pubmed/34508515 http://dx.doi.org/10.31729/jnma.5538 |
Ejemplares similares
-
Standard Operating Procedure for Specimen Collection, Packaging and Transport for Diagnosis of SARS-COV-2
por: Shrestha, Lok Bahadur, et al.
Publicado: (2020) -
Protection of our Future Generation: Use of Face Masks in Children amidst COVID-19 Era
por: Gyawali, Mallika
Publicado: (2021) -
Probable Exit Strategy Against COVID-19 of Low Resource Country like Nepal: Open Floor Discussion
por: Rajbhandari, Bibek, et al.
Publicado: (2020) -
Mouth Self-examination for Prevention and Control of Oral Cavity Cancer
por: Shrestha, Gambhir, et al.
Publicado: (2020) -
Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
por: Gujar, Shashi, et al.
Publicado: (2020)